Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients

Summary

Einstein Medical Center in Philadelphia serves a diverse group of the patient population. The majority of patients have a diverse cultural background, low literacy, and poor social-economic status. Medication adherence for chronic medical problems is in a range of 40-70%. Medication adherence among patients on oral anti-cancer therapy is not studied in detail. The main objective is to study medication adherence to oral anticancer agents in patients with low literacy and poor socio-economic status.

Eligibility

Inclusion Criteria:

* All patients on oral chemotherapeutic agents
* Clinical diagnosis of stage IV breast cancer
* Clinical diagnosis of stage III and IV colorectal cancer (not receiving concurrent radiation therapy)
* Clinical diagnosis of stage IV non-small cell lung cancer
* Clinical diagnosis of stage IV renal cell carcinoma
* Clinical diagnosis of stage IV ovarian carcinoma
* Clinical diagnosis of multiple myeloma
* Clinical diagnosis of chronic myelogenous leukemia on TKI
* Clinical diagnosis of myelodysplastic syndrome on Lenalidomide
* Adjuvant treatment for Gastro Intestinal Stromal Tumor
* Clinical diagnosis of chronic Lymphocytic Leukemia
* Clinical diagnosis of metastatic Prostate cancer
* Clinical diagnosis of hepatocellular Carcinoma
* Clinical diagnosis of stage IV Melanoma
* Clinical diagnosis of myelofibrosis/myeloproliferative neoplasms
* Age \>18 years
* ECOG Performance Status \<3

Exclusion Criteria:

* ECOG Performance Status of 3 and above
* Concurrent chemo radiation
* Non-English speaker
* Clinical diagnosis of dementia, or otherwise unable to give informed consent.
* History of non-compliance (defined as the history of 2 or more missed appointments in the clinic).
* Pregnant patients
* Nursing Home Patients
* Incarcerated

Conditions1

Locations1 site

Browse More Trials